Cannabinoid Pharmacology
Cannabidiol Gel Trial for Fragile X Syndrome Fails Primary Endpoint Amid High Placebo Response
A recent cannabidiol gel trial for Fragile X Syndrome did not meet its primary endpoint, largely due to a high placebo response. Explore implications for…
Access & Prescribing (Australia & Global)
Indiana Governor Signals Increased Likelihood of Medical Cannabis Legalization Following Federal Rescheduling and RAND Study Findings
Indiana Governor Mike Braun signals a shift in medical cannabis policy after federal rescheduling. A RAND study details Indiana's $1.8B illicit market, $1…
Global Regulatory Updates
Louisiana Lawmakers Advance Bill Increasing Cannabis Penalties Near Schools and Colleges
Louisiana lawmakers have advanced HB 568, a bill that significantly increases cannabis penalties near schools and colleges, threatening jail time. This de…
Clinical Trials & Medical Research
Public Support for Medical Cannabis Rescheduling Strong, Johns Hopkins Study Finds After Federal Reclassification
A new Johns Hopkins study reveals strong public support for medical cannabis rescheduling in the US, with 92.4% wanting it off Schedule I. Learn key motiv…
Access & Prescribing (Australia & Global)
Federal Rescheduling Could Trigger Medical Cannabis Access in South Carolina Under Existing State Laws
Explore how federal cannabis rescheduling could activate existing South Carolina laws, potentially granting patients medical cannabis access. This analysi…
Equities, Investment & Market Trends
Oklahoma Judge Lifts Medical Cannabis Cultivation License Suspension for Cedric Gardens Inc.
An Oklahoma administrative law judge has reinstated Cedric Gardens' medical cannabis cultivation license, overturning an OMMA suspension. This ruling high…
Global Regulatory Updates
Navigating the Legal Landscape: The Question of CBD Gummies in Texas by 2026
Explore the evolving regulatory environment surrounding CBD gummies in Texas as 2026 approaches. This analysis examines the critical factors influencing l…
Cannabinoid Pharmacology
Clinics Prescribing Medicinal Cannabis for Anxiety and Depression Amidst Call for More Evidence
Explore the ongoing discussion surrounding medicinal cannabis prescriptions for anxiety and depression in Australia. While patient interest is high, exper…
Agronomy & Cultivation Science
Industrial Hemp Construction: Building a Greener Future with Hempcrete and Carbon-Negative Materials
Explore how industrial hemp construction, particularly hempcrete, is revolutionizing the building industry with sustainable, carbon-negative materials. Le…
Australian Cannabis Policy & Law
DEA Launches Online Registration Portal for State-Licensed Medical Cannabis Firms, Offering Tax Relief and Banking Access
The DEA has launched an online registration portal for state-licensed medical cannabis firms, providing federal recognition, significant tax relief, and a…
